Therapy consists of blood clotting factors II, IX and X Prothrombin complex concentrates. Described as factor IX complex, it is commonly used during heavy bleeding and includes reverse anticoagulation in emergency situations.
MARKET DYNAMICS
Increasing prescribing anticoagulants, in particular warfarin, and an increased incidence of bleeding disorders are projected to expand the marketplace. Compared to fresh-frozen plasma and others, PCC provides a variety of benefits that make it ideally suited to life-threatening situations. A total of 68,703,141 I.U. According to the Federation of World Hemophilia. Plasma-derived factor IX was used in Europe in 2020. Increased use of the factor IX complex would therefore likely lead to the growth of this market during the forecast era.
MARKET SCOPE
The "Prothrombin Complex Concentrate Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Prothrombin Complex Concentrate Market with detailed market segmentation by type, application, and end use. The Prothrombin Complex Concentrate Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Prothrombin Complex Concentrate Market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Prothrombin Complex Concentrate Market is segmented on the basis of type, application, and end use. Based on product type, the market is segmented as 3 Factor PCC, 4 Factor PCC. Based on application, the market is segmented as Acquired Coagulation Factor Deficiency and Congenital Coagulation Factor Deficiency. Based on end use, the market is segmented as Hospitals and Clinics, Ambulatory Surgical Centers, and Others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Prothrombin Complex Concentrate Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Prothrombin Complex Concentrate Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Prothrombin Complex Concentrate Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Prothrombin Complex Concentrate Market in these regions.
MARKET PLAYERS
The report covers key developments in the Prothrombin Complex Concentrate Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Prothrombin Complex Concentrate Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Prothrombin Complex Concentrate Market in the global market. Below mentioned is the list of few companies engaged in the Prothrombin Complex Concentrate Market.
The report also includes the profiles of key players in Prothrombin Complex Concentrate Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Takeda Pharmaceutical Company Limited
- China Biologic Products Holdings, Inc.
- Sanquin
- CSL Behring
- Kedrion S.p.A
- Octopharma AG
- Grifols, S.A.
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.